August 30: How Stable Peptide Drugs Can Be Used in Cancer Research

1970-01-01 12:00 am - 12:00 am

With the maturing of biotechnology and peptide synthesis technology, more and more peptide drugs are developed and applied in the clinic. Due to the wide indications, high safety and remarkable therapeutic effect, peptide drugs have been widely used in the prevention, diagnosis and treatment of tumor, hepatitis, diabetes, AIDS and other diseases, with a broad development prospect.

On August 7, bioLIVE R&D Week will invite Dr. Feng Yin, a researcher from Shenzhen Bay Laboratory's Pingshan Biomedical R&D & Translational Center, to share the topic of "Application of Stable Peptide Drugs in Cancer Research", and share the successful development of a series of stable peptide antagonists/degradants for important cancer targets and their applications as transport carriers through the independently developed stable peptide method.